Artigo de periodico

Statin treatment alters the expression profile of plasma exosome-derived microRNAs in patients with familial hypercholesterolemia (2025)

• Authors:
  • Hernandez, Carolina Dagli
  • Freitas, Renata Caroline Costa de
  • Luchessi, André Ducati
  • Hirata, Thiago Dominguez Crespo
  • Fajardo, Cristina Moreno
  • Borges, Jéssica Bassani
  • Oliveira, Victor Fernandes de
  • Neta, Antonia Pereira Rosa
  • Faludi, André Arpad
  • Gonçalves, Rodrigo Marques
  • Bortolin, Raul Hernandes
  • Malaquias, Vanessa Barbosa
  • Bastos, Gisele Medeiros
  • Sampaio, Marcelo Ferraz
  • Hirata, Mario Hiroyuki
  • Hirata, Rosario Dominguez Crespo
• USP affiliated authors: HERNANDEZ, CAROLINA DAGLI - FCF ; HIRATA, THIAGO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; OLIVEIRA, VICTOR FERNANDES DE - ICB ; MALAQUIAS, VANESSA BARBOSA - FCF
• Unidades: FCF; ICB
• DOI: 10.1016/j.jpet.2025.103626
• Subjects: HIPERCOLESTEROLEMIA; ESTATINAS
• Agências de fomento:
  • Financiamento FAPESP
  • Financiamento CNPq
  • Financiamento CAPES
• Language: Inglês
• Imprenta:
  • Publisher place: Amsterdam
  • Date published: 2025
• Source:
  • Título: Journal of Pharmacology and Experimental Therapeutics
  • ISSN: 0022-3565
  • Volume/Número/Paginação/Ano: v. 362, n. 7, p. 1-11 art. 103626, 2025

Informações sobre o DOI: 10.1016/j.jpet.2025.103626 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo NÃO é de acesso aberto
  
• Cor do Acesso Aberto: closed

---

Download do texto completo

Tipo	Nome	Link
	3262812.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  HERNANDEZ, Carolina Dagli et al. Statin treatment alters the expression profile of plasma exosome-derived microRNAs in patients with familial hypercholesterolemia. Journal of Pharmacology and Experimental Therapeutics, v. 362, n. 7, p. 1-11 art. 103626, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpet.2025.103626. Acesso em: 28 dez. 2025.

• APA

  Hernandez, C. D., Freitas, R. C. C. de, Luchessi, A. D., Hirata, T. D. C., Fajardo, C. M., Borges, J. B., et al. (2025). Statin treatment alters the expression profile of plasma exosome-derived microRNAs in patients with familial hypercholesterolemia. Journal of Pharmacology and Experimental Therapeutics, 362( 7), 1-11 art. 103626. doi:10.1016/j.jpet.2025.103626

• NLM

  Hernandez CD, Freitas RCC de, Luchessi AD, Hirata TDC, Fajardo CM, Borges JB, Oliveira VF de, Neta APR, Faludi AA, Gonçalves RM, Bortolin RH, Malaquias VB, Bastos GM, Sampaio MF, Hirata MH, Hirata RDC. Statin treatment alters the expression profile of plasma exosome-derived microRNAs in patients with familial hypercholesterolemia [Internet]. Journal of Pharmacology and Experimental Therapeutics. 2025 ; 362( 7): 1-11 art. 103626.[citado 2025 dez. 28 ] Available from: https://dx.doi.org/10.1016/j.jpet.2025.103626

• Vancouver

  Hernandez CD, Freitas RCC de, Luchessi AD, Hirata TDC, Fajardo CM, Borges JB, Oliveira VF de, Neta APR, Faludi AA, Gonçalves RM, Bortolin RH, Malaquias VB, Bastos GM, Sampaio MF, Hirata MH, Hirata RDC. Statin treatment alters the expression profile of plasma exosome-derived microRNAs in patients with familial hypercholesterolemia [Internet]. Journal of Pharmacology and Experimental Therapeutics. 2025 ; 362( 7): 1-11 art. 103626.[citado 2025 dez. 28 ] Available from: https://dx.doi.org/10.1016/j.jpet.2025.103626

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Integrative analysis of miRNAs and proteins in plasma extracellular vesicles of patients with familial hypercholesterolemia
• Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts
• Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia
• Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients
• Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia
• Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes
• Mycophenolic acid pharmacogenomics in kidney transplantation
• Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report
• Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling
• PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions